Beijing Tsinghua Changyu Hospital, to liver and bile pancreatic tumor patients comprehensive tracking management.

(Health Times reporter Lu Wei)
. April 15-21, 2020 is the 26th National Cancer Prevention and Control Promotion Week, Beijing Tsinghua Changxuan Hospital on April 15 thinly launched the new coronary pneumonia outbreak of liver and biliary pancreatic tumor multidisciplinary diagnosis and treatment of the whole management activities.
Professor Dong Jiahong, a member of the Chinese Academy of Engineering and executive director of Tsinghua Changyu Hospital in Beijing, led an online exchange with doctors and patients to discuss how to provide scientific diagnosis and treatment and effective management to patients with hepatobiliary pancreatic tumor sending patients in the outbreak.
"The complexity of the tumor determines the diversity of treatment methods, the relevant departments and hospitals at all levels to break the traditional medical model of 'separate' barriers, close collaboration, in order to help patients choose the best treatment and systematic treatment, with the least risk, the lowest cost to enable patients to get the most effective treatment." During the outbreak, the patient's path and doctor's treatment are limited to varying degrees, how to treat accurately, and adjust the treatment plan in a timely manner in the context of the outbreak situation is particularly important.
primary liver cancer is the fourth common malignant tumor and the second fatal cause of cancer in China. Patients with hepatobiliary pancreatic tumor are susceptible to new coronary pneumonia, and are also high-risk groups with severe illness after infection. In the case of new coronary pneumonia, remote multidisciplinary consultation (MDT) can reduce the risk of aggregation, save patients the pain of travel, optimize patient treatment.
2017, Beijing Tsinghua Changxuan Hospital has set up the MDT Center for hepatobiliary pancreatic tumors, which brings together experts from departments such as hepatobiliary surgery, hepatology, oncology, imaging, radiotherapy, intervention, pathology, clinical medicine, etc., and is committed to developing a full-scale diagnosis and treatment program for patients with multidisciplinary participation, providing tailor-made precision medical services."The so-called precision treatment is for every patient, the precise selection and accurate use of appropriate treatment, so as to achieve the best health effects with minimal medical damage and minimum medical costs," said Mr Tung, a member of the
. "In order to enable patients with hepatobiliary pancreatic tumors to get better treatment and post-disease management, Tsinghua Changyu Hospital actively provides patients with case manager sourcing services.Yan Zhe, a case manager for hepatic and biliary pancreatic tumors in
, said that the case manager of Tsinghua Changyu Hospital in Beijing comprehensively tracks patient management, such as following the clinical management path of the disease, coordinating the arrangement of various laboratory tests, participating in the assessment of the disease, coordinating the assessment of the patient, organizing multidisciplinary joint diagnosis and treatment, and monitoring and managing the implementation of the treatment plan;
in recent years, the research on drugs such as targeted treatment of liver cancer and immunotherapy has made a major breakthrough. For example, the first-line treatment-targeted drug rifatinib, the second-line treatment target drug rigofenib, and the first and currently only approved treatment of advanced liver cancer in China, the original PD-1 inhibitor Carillizumab has been in clinical promotion and application, and achieved very good results, representing liver cancer treatment into a new era.
in this context, multidisciplinary comprehensive treatment has gradually become an important part of further improving the effectiveness of liver cancer treatment. There are no obvious symptoms of liver cancer in the early stage, many patients in our country often find that it is late stage, tumor cells in the liver there is a widespread metastasis, tumor from the early local development to the late body state. Therefore, local treatment methods such as surgery, radiotherapy and intervention are difficult to meet the needs of clinical treatment. This requires a combination of systemic treatment, including liver surgery, intervention, oncology, radiotherapy, liver disease, imaging, pathology and other multidisciplinary collaboration.
.